mask
price apr usd
takeaway earn call
although opt suspend previous provid guidanc due
heighten macro uncertainti consist decis wide swath
industri compani thu far manag provid help color
morn earn call point april organ revenu
mid-teen america emea asia pac lsd
extrapol although could prove overli
pessimist depend quickli us/europ reopen also expect
report decrement margin inclus temporari cost
cut action estim payback action
assum underli decrement pre-restructur order get
also seem overli punit
chang number much result
adjust model reflect aforement manag commentari
come ep lower previou forecast
continu emb recoveri begin comp eas
tremend model ep y/i also modestli higher
prior forecast said short-cycl industri name
cover believ risk skew downsid global
recoveri becom u- w-shape natur
pt increas maintain hold rate
roll model forward price target increas base
ep forecast given modest upsid vs current share price
maintain hold rate upsid risk better expect margin perform
driven restructur payback/product faster expect recoveri
deutsch bank seek busi compani cover research report thu investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis disclosur analyst certif locat
distribut gmt
segment y/ydb varvar commentssafeti organ revenu fx divestitur organ sale increas person safeti roof granul industri adhes tape sale declin closur mask electr market automot a/m abras region organ sale america emea apactransport organ revenu fx divestitur organ sale increas electron flat advanc materi transport safeti declin commerci solut automot aerospac region organ sale emea apac america organ fx organ sale grew drug deliveri food safeti medic solut separ purif flat health inform system declin oral care region organ sale america emea organ revenu fx organ sale grew home improv home care consum health care declin stationeri offic suppli region organ sale america apac organ revenu fx strong end-market demand person safeti respir home improv gener clean solut food safeti biopharma filtrat end-market weak oral care auto oem/am gener industri commerci solut stationeri offic region america emea asia pacif consensu consensu remov gain sale busi consensu consensu incom includ corpor unalloc elimin dual credit gain sale businessreport oper consensu margin safeti impact sale increas productivitytransport impact sale declin impact acel modal acquisit impact declin healthcar oral care discretionary/prev impact sale increas productivityseg margin safeti increment april
incom statement y/ydb varvar commentsnet organ revenu fx strong end-market demand person safeti respir home improv gener clean solut food safeti biopharma filtrat end-market weak oral care auto oem/am gener industri commerci solut stationeri offic region america emea asia pacif good sale n/a- n/areport oper oper organ volume/product acel price/raw materi fxinterest expens incom pre-tax adj tax rate vs net disc ops- n/a- n/a- non-control net incom attribut n/a- adjust includ net pre-tax charg off-set relat resolut tax treatment author regard previous disclos agreement reach state minnesota resolv natur resourc damag nrd lawsuitheadlin net dilut share headlin consensu impli guidanc select bs/cf y/ydb sale n/a-
ye decemb y/i organ gain sale report oper oper expens pre-tax effect disc ops- gaap net incom attribut non-control gaap net incom attribut headlin share headlin y/i ep
ye decemb depreci chang trade work oper proce sale invest equiti stock debt financ increase/ decreas end oper proce sale free april
